Has Reeshape (Orlistat) any effect on Hypertension and Lipid profile in Overweight and Obese cardiac patients ?
Reeshape is effective for improving both weight loss and serum lipid profiles in obese patients at low and high cardiovascular disease risk. Reeshape (Orlistat) effectively manages obesity related co-morbidities, atherosclerosis risk. Therefore, Orlistat appears to have anti-atherogenic properties with significant reductions in Blood Pressure and heart rate, and may therefore have a role in the management of hypertension in Overweight and Obese patients.